We are pleased to confirm At the Limits events are sponsored by various Industry partners.
In 2018 this includes Sponsorship and Grants confirmed as follows, with a number of other sponsorship agreements awaiting confirmation and once finalised they will appear here.
Sponsors have not influenced the content or the speaker selection of the independent programmes, nor had, or will have foresight of the presentations.
Financially supported by Amgen
Funding to support “Cardiology, Diabetes and Nephrology at the Limits” in London, April 2018
By joining forces, the companies demonstrate commitment in the care of patients
with diabetes and stand together to focus on patient needs.
Novo Nordisk Ltd have sponsored the meeting and contributed to covering the fixed costs of the meeting.
Napp Pharmaceuticals Ltd and Mundipharma has financially sponsored this meeting and has had no input into the contents of the agenda.
AstraZeneca has provided sponsorship support for this programme and has had no editorial control or influence on the content of the meeting.
Boehringer Ingelheim & Lilly Alliance has provided sponsorship support for this programme and has had no editorial control or influence on the content of the meeting.
This activity has been supported by sponsorship from Roche Products Limited.
Roche Products Limited has had no control over the educational content of this activity.
2019 To be confirmed